Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Tamoxifen Prevent the Skeletal and Cardiovascular Morbidity of Chemotherapy in Premenopausal Women?

NCT00005605 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT00005605
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00005605 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Tamoxifen Prevent the Skeletal and Cardiovascular Morbidity of Chemotherapy in Premenopausal Women?
Lead sponsor
Northwestern University
Phase
Observational
Overall status
Completed
Start date
February 29, 2000
Completion date
October 31, 2005
Enrollment
79 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, osteoporosis